Clinical Trial Update: A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating ertapenem sodium for complicated urinary tract infections has completed, assessing safety, tolerability, and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection

Drugs mentioned

• Invanz (ertapenem)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Urinary Tract Infection | Phase 3 | Status: COMPLETED